Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 6/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL190294 | 0.88 | LMNA (0.42) | DNM1LMNATSHRALDH1A1HSD17B10 | |
| SCHEMBL1038114 | 0.88 | LMNA (0.42) | DNM1LMNATSHRALDH1A1HSD17B10 | |
| Fluoride SCHEMBL11099490 | 0.86 | LMNA (0.46) | DNM1LMNATSHRALDH1A1HSD17B10 | |
| Fluoride SCHEMBL3259338 | 0.86 | LMNA (0.41) | DNM1LMNATSHRALDH1A1HSD17B10 | |
| Fluoride SCHEMBL11097713 | 0.82 | LMNA (0.43) | DNM1LMNATSHRALDH1A1HSD17B10 | |
| Avridine SCHEMBL6741009 | 0.80 | LMNA (0.35) | DNM1LMNATSHRALDH1A1HSD17B10 | |
| SCHEMBL23288549 | 0.78 | DNM1 (0.37) | DNM1LMNATSHRALDH1A1HSD17B10 | |
| SCHEMBL20590751 | 0.78 | DNM1 (0.48) | DNM1TSHRALDH1A1CA12CA1 | |
| SCHEMBL10380685 | 0.78 | DNM1 (0.42) | DNM1TSHRCA12CA1CA2 | |
| SCHEMBL9705202 | 0.78 | LMNA (0.41) | DNM1LMNATSHRALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8030450-B2 | Canine RANKL and methods for preparing and using the same | INTERVET INC. (US) | 2011-10-04 | — | — | US | claimed |
| US-20090148456-A1 | CANINE RANKL AND METHODS FOR PREPARING AND USING THE SAME | SCHERING-PLOUGH ANIMAL HEALTH CORPORATION | 2009-06-11 | — | — | US | claimed |
| EP-1578305-A4 | CANINE RANKL AND METHODS FOR PREPARING AND USING THE SAME | SCHERING PLOUGH LTD (CH) | 2008-08-27 | — | — | EP | claimed |
| US-7417122-B2 | Mammalian galanin receptors | SCHERING CORPORATION (US) | 2008-08-26 | — | — | US | claimed |
| US-20070255044-A1 | MAMMALIAN GALANIN RECEPTORS | SCHERING CORPORATION | 2007-11-01 | — | — | US | claimed |
| US-20060154858-A1 | Canine rankl and methods for preparing and using the same | SCHERING-PLOUGH LTD. (CH) | 2006-07-13 | — | — | US | claimed |
| EP-1578305-A2 | CANINE RANKL AND METHODS FOR PREPARING AND USING THE SAME | Schering-Plough Ltd. (CH) | 2005-09-28 | — | — | EP | claimed |
| WO-2004052233-A2 | CANINE RANKL AND METHODS FOR PREPARING AND USING THE SAME | SCHERING-PLOUGH LTD. (CH) | 2004-06-24 | — | — | WO | claimed |
| US-20220155305-A1 | METHODS OF TREATING AND DIAGNOSING LUNG CANCER | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2022-05-19 | — | — | US | disclosed |
| US-20210315983-A1 | VACCINATION WITH CANCER NEOANTIGENS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-10-14 | — | — | US | disclosed |
| US-20210095007-A1 | ANTIBODIES THAT BIND EBOLA GLYCOPROTEIN AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2021-04-01 | — | — | US | disclosed |
| US-10894818-B2 | Antibodies that bind Ebola glycoprotein and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-01-19 | — | — | US | disclosed |
| US-10463747-B2 | Method of developing a vaccine using peptide-poly IC complexes | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2019-11-05 | — | — | US | disclosed |
| US-10202617-B2 | Expression cassette for efficient surface display of antigenic proteins | TEMASEK LIFE SCIENCES LABORATORY LIMITED (SG) | 2019-02-12 | — | — | US | disclosed |
| EP-0521318-A2 | Hepatitis C diagnostics and vaccines | LUCKY LTD. (KR) | 1993-01-07 | — | — | EP | disclosed |
| EP-0506826-A1 | ANTIBODY ANTAGONISTS OF HUMAN INTERLEUKIN-4. | SCHERING CORP (US) | 1992-10-07 | — | — | EP | disclosed |
| WO-1992006115-A1 | ANTAGONISTS OF HUMAN GAMMA INTERFERON | SCHERING CORPORATION (US) | 1992-04-16 | — | — | WO | disclosed |
| EP-0439056-A2 | Coccidiosis vaccines | F. HOFFMANN-LA ROCHE AG (CH) | 1991-07-31 | — | — | EP | disclosed |
| WO-1991009059-A1 | ANTIBODY ANTAGONISTS OF HUMAN INTERLEUKIN-4 | SCHERING CORPORATION (US) | 1991-06-27 | — | — | WO | disclosed |
| EP-0344808-A1 | Recombinant coccidiosis vaccines | F. HOFFMANN-LA ROCHE AG (CH) | 1989-12-06 | — | — | EP | disclosed |